Upfront use of gemtuzumab ozogamicin in young children with CD33-positive AML
Dror Sayar, Yoav Burstein, Bela Bielorai, Amos Toren, Rina DvirVolume:
55
Year:
2010
Language:
english
Pages:
1
DOI:
10.1002/pbc.22404
File:
PDF, 56 KB
english, 2010